| Saybrook Podiatry Associates, Pc | |
|
767 Boston Post Rd, Old Saybrook, CT 06475-2127 | |
| (860) 388-2641 | |
| (860) 395-2928 |
| Full Name | Saybrook Podiatry Associates, Pc |
|---|---|
| Type | Facility |
| Speciality | Podiatrist - Foot Surgery |
| Location | 767 Boston Post Rd, Old Saybrook, Connecticut |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1669539615 | NPI | - | NPPES |
| Provider Name | Callie Lamay |
|---|---|
| Provider Type | Practitioner - Podiatry |
| Provider Identifiers | NPI Number: 1467581769 PECOS PAC ID: 4688850050 Enrollment ID: I20110520000028 |
News Archive
Can-Fite BioPharma Ltd., a biotechnology company with a pipeline of proprietary small molecule drugs that address inflammatory and cancer diseases, today announced the Company's oncology drug candidate, CF102, has been granted Orphan Drug Designation by the European Medicines Agency (EMA) for the indication of hepatocellular carcinoma (HCC), the most common form of liver cancer.
Researchers at the Universitat de València, Universitat Politècnica de València (UPV), Doctor Peset University Hospital and the Institute of Agrochemistry and Food Technology of CSIC have designed and tested the effectiveness of a new apple snack impregnated with tangerine juice that reduces the risk of cardiovascular disease in obese children and improves their physiological well-being.
In a study published in The Journal of Experimental Medicine, researchers working at the Wihuri Research Institute and the University of Helsinki report a surprising finding that challenges current anatomy and histology textbook knowledge: Lymphatic vessels are found in the central nervous system where they were not known to exist.
Researchers have identified a gatekeeper protein that prevents pancreatic cancer cells from transitioning into a particularly aggressive cell type and also found therapies capable of thwarting those cells when the gatekeeper is depleted.
The Heart & Vascular Center of Arizona today announced the availability of Corus(TM) CAD, the first and only gene expression test to quantify the likelihood of obstructive(i) coronary artery disease (CAD) in patients with stable chest pain.
› Verified 7 days ago
| Provider Name | Kevin M Wakeham |
|---|---|
| Provider Type | Practitioner - Podiatry |
| Provider Identifiers | NPI Number: 1992834295 PECOS PAC ID: 7214113687 Enrollment ID: I20110520000072 |
News Archive
Can-Fite BioPharma Ltd., a biotechnology company with a pipeline of proprietary small molecule drugs that address inflammatory and cancer diseases, today announced the Company's oncology drug candidate, CF102, has been granted Orphan Drug Designation by the European Medicines Agency (EMA) for the indication of hepatocellular carcinoma (HCC), the most common form of liver cancer.
Researchers at the Universitat de València, Universitat Politècnica de València (UPV), Doctor Peset University Hospital and the Institute of Agrochemistry and Food Technology of CSIC have designed and tested the effectiveness of a new apple snack impregnated with tangerine juice that reduces the risk of cardiovascular disease in obese children and improves their physiological well-being.
In a study published in The Journal of Experimental Medicine, researchers working at the Wihuri Research Institute and the University of Helsinki report a surprising finding that challenges current anatomy and histology textbook knowledge: Lymphatic vessels are found in the central nervous system where they were not known to exist.
Researchers have identified a gatekeeper protein that prevents pancreatic cancer cells from transitioning into a particularly aggressive cell type and also found therapies capable of thwarting those cells when the gatekeeper is depleted.
The Heart & Vascular Center of Arizona today announced the availability of Corus(TM) CAD, the first and only gene expression test to quantify the likelihood of obstructive(i) coronary artery disease (CAD) in patients with stable chest pain.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Saybrook Podiatry Associates, Pc 767 Boston Post Rd, Old Saybrook, CT 06475-2127 Ph: (860) 388-2641 | Saybrook Podiatry Associates, Pc 767 Boston Post Rd, Old Saybrook, CT 06475-2127 Ph: (860) 388-2641 |
News Archive
Can-Fite BioPharma Ltd., a biotechnology company with a pipeline of proprietary small molecule drugs that address inflammatory and cancer diseases, today announced the Company's oncology drug candidate, CF102, has been granted Orphan Drug Designation by the European Medicines Agency (EMA) for the indication of hepatocellular carcinoma (HCC), the most common form of liver cancer.
Researchers at the Universitat de València, Universitat Politècnica de València (UPV), Doctor Peset University Hospital and the Institute of Agrochemistry and Food Technology of CSIC have designed and tested the effectiveness of a new apple snack impregnated with tangerine juice that reduces the risk of cardiovascular disease in obese children and improves their physiological well-being.
In a study published in The Journal of Experimental Medicine, researchers working at the Wihuri Research Institute and the University of Helsinki report a surprising finding that challenges current anatomy and histology textbook knowledge: Lymphatic vessels are found in the central nervous system where they were not known to exist.
Researchers have identified a gatekeeper protein that prevents pancreatic cancer cells from transitioning into a particularly aggressive cell type and also found therapies capable of thwarting those cells when the gatekeeper is depleted.
The Heart & Vascular Center of Arizona today announced the availability of Corus(TM) CAD, the first and only gene expression test to quantify the likelihood of obstructive(i) coronary artery disease (CAD) in patients with stable chest pain.
› Verified 7 days ago
John T. Carroll, Dpm Pc Podiatrist Medicare: Medicare Enrolled Practice Location: 455 Boston Post Rd, Unit #8, Old Saybrook, CT 06475 Phone: 860-510-0502 Fax: 860-510-0551 | |
Callie Lamay Dpm Llc Podiatrist Medicare: Medicare Enrolled Practice Location: 767 Boston Post Rd, Old Saybrook, CT 06475 Phone: 860-388-2641 Fax: 860-395-2928 | |
Callie Lamay, D.P.M. Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 767 Boston Post Rd, Old Saybrook, CT 06475 Phone: 860-388-2641 Fax: 860-395-2928 | |
Dr. John T Carroll, DPM Podiatrist Medicare: May Accept Medicare Assignments Practice Location: 455 Boston Post Rd Ste 8, Old Saybrook, CT 06475 Phone: 860-510-0502 Fax: 860-510-0551 | |
Dr. Kevin M. Wakeham, D.P.M. Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 767 Boston Post Rd, Old Saybrook, CT 06475 Phone: 860-388-2641 Fax: 860-395-2928 |